🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the efficacy and safety of the combinati...
Status
Completed
Location
Department of Medical Oncology, Shanghai Changzheng Hospital
Start Date
2020-06-01
Trial ID
NCT04271813
Treatments Being Tested
This is a single-arm, open-label and exploratory clinical study of Anlotini...
Status
Unknown
Location
Jiangsu Province Hospital
Start Date
2019-06-10
Trial ID
NCT04052152
Treatments Being Tested
This is a prospective single-center, open-label, phase II study evaluating ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-02-01
Trial ID
NCT06221462
Treatments Being Tested
Immunotherapy combined with anti-angiogenic therapy can achieve better resu...
Status
Unknown
Location
Changzhou Cancer Hospital of Soochow University
Start Date
2019-05-08
Trial ID
NCT04192682
Treatments Being Tested
Small cell lung cancer (SCLC) accounts for 10-15% of lung cancer. More than...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2019-09-11
Trial ID
NCT04055792
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of transar...
Status
Completed
Location
Gao-Jun Teng
Start Date
2022-12-28
Trial ID
NCT05332496
Treatments Being Tested
The purpose of this study is to observe and evaluate the efficacy and safet...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04813406
Treatments Being Tested
The Purpose of This Study is to Evaluate the Efficacy and Safety of Gemox c...
Status
Unknown
Location
Multiple Locations
Start Date
2023-10-01
Trial ID
NCT06033118
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Sintili...
Status
Completed
Location
Xinhua Hospital
Start Date
2019-07-01
Trial ID
NCT04004572
Treatments Being Tested
Cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors combined with hormonal...
Status
Recruiting
Location
Hunan Provincial Tumor Hospital
Start Date
2024-12-05
Trial ID
NCT06734533